Sana Biotechnology Inc (SANA) Stock Forecast & Price Target
Sana Biotechnology Inc · NASDAQ
$3.29+0.01 (+0.46%)
15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 4 firms covering Sana Biotechnology Inc, 4 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $7.00 to $8.00, so the covering firms are broadly aligned. The average target of $7.25 sits 120% above the current $3.29. The rating mix has stayed broadly stable, with Buy-side ratings easing from 6 to 4 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.12 next quarter toward $-0.52 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 ratings
Moderate Buy
Strong Buy00%
Buy4100%
Hold00%
Sell00%
Strong Sell00%
Based on 4 analysts giving stock ratings to Sana Biotechnology Inc.
As of Jul, 4 of 4 firms rate SANA a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
SANA EPS & revenue forecast
EPS · NEXT QUARTER
$-0.12
Range $-0.14 – $-0.10 · 4 analysts · -19% YoY
Next period, 4 analysts expect Sana Biotechnology Inc to earn $-0.12 a share (range $-0.14 – $-0.10), versus $-0.15 a year earlier. Full-year consensus is $-0.58, growing to $-0.52 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 4 analysts
Revenue is expected to reach $0 (range $0 – $0). Full-year consensus is $0, rising to $0 next year.
Top analysts covering Sana Biotechnology Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on SANA.
#1
Reni J. Benjamin
JMP Securities · Rank #290
Buy
$8.00+142.8% to target
Overall win rate
33%
+ Follow
#2
Emily Bodnar
HC Wainwright & Co. · Rank #338
Buy
$7.00+112.4% to target
Overall win rate
22%
+ Follow
#3
MF
Marc Frahm
TD Cowen
Buy
$2027.00+61417.5% to target
Coverage
—
+ Follow
#4
MF
Martin Fan
Wedbush
Buy
$7.00+112.4% to target
Coverage
—
+ Follow
#5
SS
Samantha Semenkow
Citigroup
Buy
$12.00+264.2% to target
Coverage
—
+ Follow
SANA stock forecast FAQ
What is SANA's average 12-month price target?+
The 3 analysts with a live target average $7.25 for Sana Biotechnology Inc over the next 12 months, ranging from a $8.00 high to a $7.00 low.
Is SANA stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 4 analyst ratings, 4 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for SANA?+
The Street-high target is $8.00 (Citizens), and the Street-low is $7.00 (Wedbush). The average of all 3 active targets is $7.25.
How many Wall Street analysts cover SANA?+
4 analysts have an active rating on Sana Biotechnology Inc, and 3 firms carry a live 12-month price target.
Who is the most accurate analyst covering SANA?+
Among analysts who currently cover SANA, Reni J. Benjamin of JMP Securities has the strongest overall Quantellect track record (Rank #290). Their current call is Buy with a $8.00 target.
What is Sana Biotechnology Inc's projected EPS for next quarter?+
The consensus estimate is $-0.12 per share (range $-0.14 – $-0.10) across 4 analysts. Full-year EPS is projected at $-0.58, rising to $-0.52 the following year.
How much revenue is Sana Biotechnology Inc expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $0, growing to $0 next year.
Have analysts been upgrading or downgrading SANA lately?+
As of Jul, 4 of 4 firms rate SANA a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their SANA calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
